Specialized testing can help doctors ensure they are getting the right treatment to the right patient at the right time -- but not everyone has access.
This testing, called “biomarker testing”, identifies markers or mutations in a patient’s cancer cells. The results of biomarker tests can help determine the best treatment plan for a specific patient, leading to improved survivorship and better quality of life.
Unfortunately, not all cancer patients have access to these groundbreaking tests. Many insurance plans won’t cover this testing, even when it’s supported by medical and scientific research.
That is why we are asking Rhode Island lawmakers to require insurance plans cover biomarker testing when it’s needed.
